N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients

Clinical Trial ID NCT00780962

Rank	Title	Journal	Year	PubWeight™‹?›
1	N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.	N Engl J Med	2006	5.63
2	Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.	JAMA	2003	5.10
3	Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.	Circulation	2002	4.99
4	Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.	JAMA	2004	4.97
5	A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.	J Am Coll Cardiol	2003	3.29
6	What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?	Ann Emerg Med	2003	2.20
7	Renal failure after percutaneous coronary intervention is associated with high mortality.	Catheter Cardiovasc Interv	2005	2.00
8	Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol.	Ann Emerg Med	1991	1.82
9	Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.	J Am Coll Cardiol	2004	1.80
10	The incidence of contrast-induced nephropathy in trauma patients.	Eur J Emerg Med	2008	0.92
11	Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.	J Vasc Surg	2004	0.86